Clinical Trial

A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective study to assess the burden of existing or hidden cardiovascular (CV) and renal disease in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a Hong Kong public hospital setting. By implementing a chronic obstructive pulmonary disease (COPD) discharge care bundle with integrated CV/renal screening, the study aims to quantify undiscovered disease prevalence, evaluate risk factors for future exacerbations, and compare re-admission rates against historical controls, ultimately informing integrated cardiopulmonary management strategies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-07.
Trial Details
NCT Number NCT07344285
Lead Sponsor Chinese University of Hong Kong
Conditions COPD
Enrollment 150 participants
Start Date 2026-01-15
Primary Completion 2029-01-16 (estimated)
Study Completion 2029-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-01-21